Highlights
NASDAQ: SPHS       Sophiris Bio
Last Price Today's Change   Day's Range   Trading Volume
0.36   +0.007 (1.98%)  0.36 - 0.37  152,800

Overview

 
Avg Volume (4 weeks):178,568
4 Weeks Range:0.341 - 0.53
4 Weeks Price Volatility (%):
10.05%
52 Weeks Range:0.34 - 2.19
52 Weeks Price Volatility (%):
1.08%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is a genetically modified recombinant protein which is selectively activated by enzymatically active prostate-specific antigen (PSA), which is only present in the prostate, leading to localized cell death and tissue disruption without damage to neighboring tissue and nerves. Geographically all the operations are functioned through the regions of Canada.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers